Clinical Trial Update: Genetic Polymorphysm of Cholesterol 24 S Hydroxylase in Patients With Glaucoma and AMD [NA]

View source ↗

Summary

A completed clinical trial investigating genetic polymorphism of cholesterol 24S-hydroxylase in patients with glaucoma and age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Glaucoma

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Glaucoma | NA | Status: COMPLETED